Clinical Trial Update: AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial investigates AMG 706 in combination with gemcitabine for patients with advanced solid tumors or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lymphoma
• Lymphoproliferative Disorder

Drugs mentioned

• AMG 706 (motesanib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer, Lymphoma | Phase 1 | Status: UNKNOWN